AZN
Price
$81.70
Change
-$0.07 (-0.09%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
253.3B
62 days until earnings call
PFE
Price
$24.64
Change
+$0.10 (+0.41%)
Updated
Sep 5, 12:08 PM (EDT)
Capitalization
139.52B
60 days until earnings call
Interact to see
Advertisement

AZN vs PFE

Header iconAZN vs PFE Comparison
Open Charts AZN vs PFEBanner chart's image
AstraZeneca
Price$81.70
Change-$0.07 (-0.09%)
Volume$41.31K
Capitalization253.3B
Pfizer
Price$24.64
Change+$0.10 (+0.41%)
Volume$40.96K
Capitalization139.52B
AZN vs PFE Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. PFE commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Hold and PFE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (AZN: $81.78 vs. PFE: $24.54)
Brand notoriety: AZN and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 69% vs. PFE: 101%
Market capitalization -- AZN: $253.3B vs. PFE: $139.52B
AZN [@Pharmaceuticals: Major] is valued at $253.3B. PFE’s [@Pharmaceuticals: Major] market capitalization is $139.52B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $665.99B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, AZN is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 3 TA indicator(s) are bullish while PFE’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 3 bullish, 4 bearish.
  • PFE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZN is a better buy in the short-term than PFE.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +2.24% price change this week, while PFE (@Pharmaceuticals: Major) price change was -0.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.98%. For the same industry, the average monthly price growth was +3.80%, and the average quarterly price growth was +10.18%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

PFE is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.98% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($253B) has a higher market cap than PFE($140B). AZN has higher P/E ratio than PFE: AZN (30.80) vs PFE (12.98). AZN YTD gains are higher at: 27.480 vs. PFE (-2.524). PFE has higher annual earnings (EBITDA): 20.2B vs. AZN (16.8B). PFE has more cash in the bank: 13.2B vs. AZN (7.11B). AZN has less debt than PFE: AZN (32.8B) vs PFE (60.9B). PFE has higher revenues than AZN: PFE (63.8B) vs AZN (56.5B).
AZNPFEAZN / PFE
Capitalization253B140B181%
EBITDA16.8B20.2B83%
Gain YTD27.480-2.524-1,089%
P/E Ratio30.8012.98237%
Revenue56.5B63.8B89%
Total Cash7.11B13.2B54%
Total Debt32.8B60.9B54%
FUNDAMENTALS RATINGS
AZN vs PFE: Fundamental Ratings
AZN
PFE
OUTLOOK RATING
1..100
1718
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
34100
SMR RATING
1..100
4562
PRICE GROWTH RATING
1..100
4954
P/E GROWTH RATING
1..100
8297
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (4) in the Pharmaceuticals Major industry is in the same range as AZN (23). This means that PFE’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (34) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (100). This means that AZN’s stock grew significantly faster than PFE’s over the last 12 months.

AZN's SMR Rating (45) in the Pharmaceuticals Major industry is in the same range as PFE (62). This means that AZN’s stock grew similarly to PFE’s over the last 12 months.

AZN's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as PFE (54). This means that AZN’s stock grew similarly to PFE’s over the last 12 months.

AZN's P/E Growth Rating (82) in the Pharmaceuticals Major industry is in the same range as PFE (97). This means that AZN’s stock grew similarly to PFE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNPFE
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
Bearish Trend 29 days ago
44%
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 4 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NFLY17.300.25
+1.47%
YieldMax NFLX Option Income Strategy ETF
SCHM29.670.34
+1.16%
Schwab US Mid-Cap ETF™
BSCX21.440.13
+0.61%
Invesco BulletShares 2033 Corp Bd ETF
JEMB52.490.26
+0.49%
Janus Henderson Em Mkts Dbt Hrd Ccy ETF
FDAT21.810.09
+0.41%
Tactical Advantage ETF

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.40%
GSK - AZN
63%
Loosely correlated
+0.64%
NVS - AZN
61%
Loosely correlated
+0.15%
SNY - AZN
50%
Loosely correlated
-9.14%
AZNCF - AZN
48%
Loosely correlated
-0.16%
PFE - AZN
47%
Loosely correlated
-1.01%
More